The Combination of Novel Low Molecular Weight Inhibitors of RAF (LBT613) and Target of Rapamycin (RAD001) Decreases Glioma Proliferation and Invasion

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Evaluation of the Immunologic Impact of RAF Inhibitors to Guide Optimal Combination of RAF Inhibitors and Immunotherapy for the Treatment of Advanced Melanoma

2014English

Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Mechanistic Target of Rapamycin Inhibitors: Successes and Challenges as Cancer Therapeutics

2019English

The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

Molecular Organization of Target of Rapamycin Complex 2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Novel HSP90 Inhibitors Effectively Target Functions of Thyroid Cancer Stem Cell Preventing Migration and Invasion

Surgery
Surgery
2016English

The Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Early Breast Cancer: Results of a Pre-Operative Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck

Cancer Research
Cancer ResearchOncology
2005English

MicroRNA-384 Inhibits Proliferation Migration and Invasion of Glioma by Targeting at CDC42

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy